Table 1.
|
Time in training quadrant |
Time in opposite quadrant |
Platform crossing latency |
---|---|---|---|
Salinea (n = 14) | 21.7 ± 1.0b | 5.8 ± 1.1b | 8.1 ± 1.1b |
Propranolola | |||
1.0 mg/kg (n = 11) | 20.4 ± 1.1 | 5.9 ± 1.2 | 10.1 ± 1.7 |
3.0 mg/kg (n = 11) | 21.1 ± 1.7 | 7.9 ± 2.3 | 8.4 ± 1.6 |
Xamoterola | |||
3.0 mg/kg (n = 10) | 21.1 ± 1.9 | 7.8 ± 1.0 | 19.9 ± 5.8* |
10.0 mg/kg (n = 9) |
17.4 ± 1.8*
|
9.0 ± 1.4 |
28.8 ± 6.6**
|
* p < 0.05; **p < 0.01 compared with the saline group.
Drugs were administered subcutaneously in a volume of 2.0 ml/kg 60 min before the 60 sec probe trial.
Values are expressed in seconds (mean ± SEM).